Japanese and US researchers, led by the Cincinnati Children’s Hospital, have completed the first-ever human trial testing the viability of enteral ventilation, where patients with severe respiratory failure could potentially have oxygen delivered through the intestine, allowing the lungs to recover and to prevent further injury.
The procedure’s safety and tolerability was examined on 27 healthy male adults in Japan, who had oxygen-rich fluid pumped into their anus.
“This is the first human data, and the results are limited solely to demonstrating the safety of the procedure and not its effectiveness,” said researcher Takanori Takebe, MD, PhD, from the Cincinnati Children’s and the University of Osaka. “But now that we have established tolerance, the next step will be to evaluate how effective the process is for delivering oxygen to the bloodstream.”
This research first came about after scientists had studied a type of bottom-feeding fish that swallows air from the surface of the water and absorbs oxygen through its gut, supplementing gill function in poor quality conditions. If humans were able to safely absorb super-oxygenated liquid through their colon, into their bloodstream, it has the potential to provide life-saving emergency treatment to people with blocked airways caused by injury or inflammation, or when lung function has been severely compromised.
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) will begin its annual distribution of RABORAL V-RG®, an oral rabies vaccine (ORV) bait, in select areas in the eastern United States to prevent the spread of raccoon rabies into America’s heartland.
Rabies is a serious public health concern. While rabies is almost always fatal once symptoms appear, it also is 100% preventable. Human exposures can be successfully remedied if medical attention is sought immediately following exposure. Costs associated with rabies detection, prevention, and control may exceed $500 million annually in the United States. According to the Centers for Disease Control and Prevention (CDC), about 90 percent of reported rabies cases in the United States are in wildlife.
APHIS and its cooperators will begin distributing ORV baits on or about Aug. 13, 2025, across rural areas by airplane and in suburban or urban areas by helicopter, vehicle, and bait station. ORV baits are coated with a fishmeal attractant and are packaged in two-inch plastic sachets or one-inch square cubes.
The RABORAL V-RG® vaccine is safe for many animals, including domestic dogs and cats. Humans and pets cannot get rabies from contact with the baits but should leave them undisturbed if they are encountered. Dogs that consume many baits may experience a temporary upset stomach, but there are no long-term health risks. If people come in contact with baits, they should immediately wash the contact area with warm water and soap.
ORV baits will be distributed during the following time periods and based out of airports in the cities listed below:
In Northeast to Mid-Atlantic states during August:
The Houlton, Maine, project will cover parts of northern Maine and distribute approximately 713,000 ORV baits by airplane and vehicle.
The Brockport, N.Y., project will include areas in western New York and distribute approximately 100,000 ORV baits by airplane. In addition to RABORAL V-RG®, APHIS will distribute another ORV bait, ONRAB, in select areas of New York as part of an ongoing field assessment.
The North Lima, Ohio, project will involve distribution of approximately 729,000 ORV baits in parts of western Pennsylvania. Field assessment of ONRAB will also occur in western Pennsylvania at the same time.
The Buckhannon, W.Va., project will include portions of western Pennsylvania and West Virginia, distributing approximately 364,000 ORV baits by airplane and vehicle. ONRAB field assessment also will take place in select areas of West Virginia.
In Massachusetts from mid-September through mid-October:
The Cape Cod, Mass., project will cover parts of peninsular and mainland Massachusetts and distribute more than 74,000 ORV baits by helicopter, bait station, and vehicle.
In Southern states during October:
The Abingdon, Va., project will cover parts of North Carolina, Tennessee, Virginia and a small portion of southern West Virginia, distributing more than 634,000 ORV baits by airplane, helicopter, and vehicle.
The Andrews, N.C., project will include areas in western North Carolina and north Georgia and will distribute 410,000 ORV baits by airplane, helicopter and vehicle.
The Dalton, Ga., project will cover areas in Alabama, Georgia, North Carolina, and Tennessee, distributing approximately 690,000 ORV baits by airplane and helicopter.
The Gadsden, Ala., project will cover parts of northeast and central Alabama (including the Greater Birmingham area) and distribute approximately 718,000 baits by airplane, helicopter, and vehicle.
Friends I have watched decline into alcoholism all displayed this trait.
They were all good people and loved good times, but after years of abuse everything about them declined into dysfunction.
If you know a young person like this, appropriate measures should be taken quickly, before it’s too late.
My nephew started drinking vodka when he was nine years old. Today he is dead.
This gene is a good candidate for gene therapy.
Alcoholism harms not only the alcoholics but also virtually everyone they come into contact with.
If there is a clear, strong genetic factor behind alcoholism, people with that gene should be banned from politics (where today they are functioning very well, for themselves) and probably many other responsible endeavors.
Alcoholics are simply incapable of reasoning well. ABN
Some of the most common medications taken by tens of millions of Americans leave a lasting impact on the body long after a person stops taking them, according to new research.
Beta-blockers, commonly prescribed for high blood pressure and heart conditions, were linked to changes in gut bacteria that were detectable even when people had stopped taking them several years earlier, according to a new study by Estonian researchers.
The same held true for anti-anxiety medications, part of the benzodiazepine class, including Xanax and Valium. Antidepressants had similar carryover effects, as did proton pump inhibitors, medications millions take for acid reflux and heartburn.
The microbiome is the body’s collection of beneficial bacteria. Its health relies on a diverse population of bacteria to fight disease, absorb nutrients and regulate immune and metabolic systems. It is influenced by everything from diet and lifestyle to the medications a person takes, including common prescription drugs.
The new study confirmed that commonly prescribed medications, ranging from antibiotics to antidepressants, consistently reduce the diversity of gut bacteria, sometimes for years.
A less diverse microbiome is linked to a weaker gut barrier, chronic inflammation and a compromised immune system. This state of imbalance, known as dysbiosis, creates a state of chronic inflammation and weakened immune defense that is a recognized breeding ground for cancer development, specifically, colorectal cancer.
Dysbiosis creates a gut environment dominated by cancer-promoting bacteria, which can trigger tumor growth by stimulating blood vessel formation, uncontrolled cell division and the evasion of cell death.
To investigate the long-term effects of medications on gut bacteria, an Estonian study genetically analyzed stool samples from 2,509 adults.
Colonoscopies also disrupt the gut biome. The linked article has a graph showing the absolute rate of colon cancer in people under fifty is less than six per 100,000. Beware of click-bait stories about the relative ratealmost doubling over the past 20 years. ABN
• Alzheimer’s disease is commonly thought to result from abnormal plaque buildup in the brain that gradually destroys brain tissue. As a result, almost all Alzheimer’s research has been directed toward eliminating amyloid, even after the basis for much of this work was shown to stem from fraudulent research.
•As such, despite decades of research and billions of dollars spent, this model has completely failed to produce useful results. The costly “groundbreaking” Alzheimer’s drugs only slightly slow dementia progression—at the expense of causing brain bleeding and swelling in over a quarter of those treated.
•In contrast, numerous affordable treatments have been developed for Alzheimer’s disease that target the root causes of the disorder, producing significant benefits at a fraction of the cost and without any toxicity.
•One neurologist, for example, proposed that amyloid serves a protective function in the brain and treats Alzheimer’s by identifying the underlying process causing dementia (which can often be diagnosed through symptoms). Remarkably, despite the method being proven in clinical research, awareness of it or the fact there are completely different types of “Alzheimer’s disease” which require different treatments remains almost nonexistent.
•Likewise, a strong case can be made that impaired cerebral circulation, along with impaired venous and lymphatic drainage, plays a pivotal role in Alzheimer’s disease.
•This article will review the common causes of cognitive impairment and dementia (e.g., cells becoming trapped in a shocked state where they no longer function) along with the forgotten treatments for neurodegenerative disorders—some of which, like DMSO, have extensive evidence supporting their use.
Scientists have discovered that DMT, a natural compound found in plants and even the human brain, can dramatically reduce brain damage caused by stroke. The psychoactive molecule, long known for its hallucinogenic effects, restored the blood-brain barrier and reduced inflammation in animal and cell studies. These findings suggest that DMT could complement existing stroke treatments, potentially transforming recovery outcomes.
Mortality is an indisputable outcome and thus a reliable statistical marker of the danger of the covid vaxxes.
But where there is mortality there is sure to be many times more instances of morbidity.
Factor this morbidity into the rise in colon cancers, strokes, other cancers, and more.
Whether they were designed as bioweapons or not, the covid mRNA vaxxes have worked like bioweapons, including probable insertion into the human genome of deleterious genetic traits. ABN
Bowel preparation for colonoscopy significantly affects Bifidobacterium, a beneficial genus of gut bacteria. Studies have shown a decrease in Bifidobacterium abundance following bowel preparation, with one study noting its reduction in fecal samples one month after the procedure
This change is part of broader alterations in the gut microbiota, including a significant decrease in Firmicutes and an increase in Proteobacteria immediately after cleansing, with Bifidobacterium identified as one of the bacterial members involved in long-term changes
The disruption to Bifidobacterium and other beneficial microbes can persist for days to weeks, potentially contributing to post-procedural symptoms like bloating and pain
However, research suggests that probiotic supplementation, including strains of Bifidobacterium, may help restore microbial balance and reduce these adverse effects For instance, a probiotic formulation containing Bifidobacterium species was found to restore intestinal dysbacteriosis and reduce pathogen abundance
While some studies indicate that the gut microbiota, including Bifidobacterium, may return to baseline levels within 14 days after the procedure , others report persistent changes in microbial composition, including reduced Lactobacillaceae (a family closely related to Bifidobacterium) and altered diversity, suggesting a more prolonged impact in certain individuals
The extent and duration of these changes may depend on the specific bowel preparation agent used and individual factors
American Buddhist Net 